DKK450.60
0.09% today
Copenhagen, Jul 18, 02:16 pm CET
ISIN
DK0060336014
Symbol
NSIS B
Industry

Novonesis Target price 2025 - Analyst rating & recommendation

Novonesis Classifications & Recommendation:

Buy
74%
Hold
17%
Sell
9%

Novonesis Price Target

Target Price DKK522.75
Price DKK451.00
Potential
Number of Estimates 20
20 Analysts have issued a price target Novonesis 2026 . The average Novonesis target price is DKK522.75. This is higher than the current stock price. The highest price target is
DKK605.85 34.33%
register free of charge
, the lowest is
DKK392.89 12.88%
register free of charge
.
A rating was issued by 23 analysts: 17 Analysts recommend Novonesis to buy, 4 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Novonesis stock has an average upside potential 2026 of . Most analysts recommend the Novonesis stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Billion DKK 28.61 31.87
59.73% 11.39%
EBITDA Margin 22.04% 37.73%
20.46% 71.21%
Net Margin 7.98% 20.32%
52.78% 154.73%

18 Analysts have issued a sales forecast Novonesis 2025 . The average Novonesis sales estimate is

DKK31.9b
Unlock
. This is
13.05% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
DKK34.0b 7.33%
Unlock
, the lowest is
DKK29.8b 18.63%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 DKK28.6b 59.73%
2025
DKK31.9b 11.39%
Unlock
2026
DKK34.7b 8.76%
Unlock
2027
DKK37.1b 7.04%
Unlock
2028
DKK39.0b 5.11%
Unlock
2029
DKK39.8b 2.01%
Unlock
2030
DKK42.3b 6.36%
Unlock
2031
DKK45.1b 6.70%
Unlock
2032
DKK47.9b 6.05%
Unlock

18 Novonesis Analysts have issued a net profit forecast 2025. The average Novonesis net profit estimate is

DKK6.5b
Unlock
. This is
76.44% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
DKK7.4b 101.06%
Unlock
, the lowest is
DKK5.1b 39.90%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 DKK2.3b 24.58%
2025
DKK6.5b 183.75%
Unlock
2026
DKK7.3b 12.66%
Unlock
2027
DKK8.2b 11.99%
Unlock
2028
DKK9.2b 12.11%
Unlock
2029
DKK9.1b 0.61%
Unlock
2030
DKK9.6b 5.58%
Unlock
2031
DKK9.5b 1.68%
Unlock
2032
DKK9.9b 5.00%
Unlock

Net Margin

2024 7.98% 52.78%
2025
20.32% 154.73%
Unlock
2026
21.05% 3.59%
Unlock
2027
22.02% 4.61%
Unlock
2028
23.49% 6.68%
Unlock
2029
22.89% 2.55%
Unlock
2030
22.72% 0.74%
Unlock
2031
20.93% 7.88%
Unlock
2032
20.72% 1.00%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share DKK 4.97 13.89
54.36% 179.48%
P/E 32.47
EV/Sales 6.90

18 Analysts have issued a Novonesis forecast for earnings per share. The average Novonesis EPS is

DKK13.89
Unlock
. This is
75.60% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
DKK15.83 100.13%
Unlock
, the lowest is
DKK11.02 39.32%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 DKK4.97 54.36%
2025
DKK13.89 179.48%
Unlock
2026
DKK15.65 12.67%
Unlock
2027
DKK17.53 12.01%
Unlock
2028
DKK19.65 12.09%
Unlock
2029
DKK19.53 0.61%
Unlock
2030
DKK20.62 5.58%
Unlock
2031
DKK20.27 1.70%
Unlock
2032
DKK21.29 5.03%
Unlock

P/E ratio

Current 57.02 38.88%
2025
32.47 43.05%
Unlock
2026
28.82 11.24%
Unlock
2027
25.73 10.72%
Unlock
2028
22.95 10.80%
Unlock
2029
23.09 0.61%
Unlock
2030
21.87 5.28%
Unlock
2031
22.25 1.74%
Unlock
2032
21.19 4.76%
Unlock

Based on analysts' sales estimates for 2025, the Novonesis stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 6.00 28.57%
2025
6.90 15.06%
Unlock
2026
6.35 8.05%
Unlock
2027
5.93 6.58%
Unlock
2028
5.64 4.86%
Unlock
2029
5.53 1.97%
Unlock
2030
5.20 5.98%
Unlock
2031
4.87 6.28%
Unlock
2032
4.60 5.70%
Unlock

P/S ratio

Current 5.71 27.16%
2025
6.57 15.01%
Unlock
2026
6.04 8.05%
Unlock
2027
5.64 6.58%
Unlock
2028
5.37 4.86%
Unlock
2029
5.26 1.97%
Unlock
2030
4.95 5.98%
Unlock
2031
4.63 6.28%
Unlock
2032
4.37 5.71%
Unlock

Current Novonesis Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BERENBERG
Locked
Locked
Locked Mar 31 2025
JEFFERIES
Locked
Locked
Locked Mar 24 2025
REDBURN ATLANTIC
Locked
Locked
Locked Mar 21 2025
DNB MARKETS
Locked
Locked
Locked Feb 11 2025
BERENBERG
Locked
Locked
Locked Dec 08 2024
BNP PARIBAS EXANE
Locked
Locked
Locked Nov 13 2024
REDBURN ATLANTIC
Locked
Locked
Locked Nov 10 2024
Analyst Rating Date
Locked
BERENBERG:
Locked
Locked
Mar 31 2025
Locked
JEFFERIES:
Locked
Locked
Mar 24 2025
Locked
REDBURN ATLANTIC:
Locked
Locked
Mar 21 2025
Locked
DNB MARKETS:
Locked
Locked
Feb 11 2025
Locked
BERENBERG:
Locked
Locked
Dec 08 2024
Locked
BNP PARIBAS EXANE:
Locked
Locked
Nov 13 2024
Locked
REDBURN ATLANTIC:
Locked
Locked
Nov 10 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today